Latest ArticlesTo explore the clinical efficacy of Tiaogan Xifeng (Liver-Regulating and Wind-Extinguishing) Acupuncture Therapy combined with conventional western medicine to treat children with tourette's syndrome (spleen deficiency and liver hyperactivity syndrome).
88 children with tourette's syndrome (spleen deficiency and liver hyperactivity syndrome) who were treated in Kaifeng Hospital of Traditional Chinese Medicine from September 2022 to January 2025 were selected for the study, and they were randomly divided into two groups, and the each group had 44 cases. The western medicine group received conventional western medicine therapy treatment, while the combination group received Tiaogan Xifeng Acupuncture Therapy on the basis of western medicine group. The traditional Chinese medicine syndrome scores, severity of symptoms [Yale global tic severity scale (YGTSS)], and neurotransmitter levels [Norepinephrine (NE), γ-aminobutyric acid (GABA), dopamine (DA)] of children before and after treatment were compared in two groups, and the clinical efficacy and adverse drug reactions in two groups of children were compared.
After treatment, the traditional Chinese medicine syndrome score, YGTSS score and the levels of NE and DA in two groups decreased (P < 0. 05), and those in the combination group were lower (P < 0.05). After treatment, the level of GABA in two groups increased (P <0.05), and that in combination group was higher (P < 0.05). The total effective rate of treatment in the combination group was higher than that in the western medicine group (P < 0.05). There was no statistically significant difference in the incidence of adverse reactions among in two groups (P > 0.05).
The Tiaogan Xifeng Acupuncture Therapy combined with conventional western medicine to treat children with tourette's syndrome (spleen deficiency and liver hyperactivity syndrome) has good clinical efficacy, and the patient's condition and neurotransmitter levels have significantly improved, and the risk of adverse reactions in children is low.
To explore and analyze the application effect of Banxia Xiexin Decoction on patients with locally advanced gastric cancer during postoperative SOX regimen chemotherapy, and to analyze its influence on immunity and nutritional status of patients.
A total of 118 patients with locally advanced gastric cancer who visited department of gastrointestinal surgery of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine from May 2021 to May 2024 were included. They were randomly divided into the conventional group and the combined group using a random number table (simple random grouping method), with 59 cases in each group. The patients in the conventional group received SOX regimen chemotherapy after surgery, whereas the patients in the combined group were added with Banxia Xiexin Decoction. The changes of tumor factors, immune factors, gastrointestinal function and nutritional indicators were observed in the two groups after treatment.
After treatment, the levels of carcinoembryonic antigen, vascular endothelial growth factor, matrix metalloproteinase-9 and other tumor factors in the combined group were lower than those in the conventional group (P < 0.05). The levels of diamine oxidase and fecal calprotectin in the combined group were lower while the level of motilin was higher compared to the conventional group (P <0.05). The neutrophil-to-lymphocyte ratio and interleukin-6 in the combined group were lower compared with those in the conventional group while the proportion of CD8 + T was higher (P <0.05). The levels of albumin, prealbumin and transferrin and body mass in the combined group were higher than those in the conventional group (P <0.05). In terms of treatment safety, the incidence rates of adverse chemotherapy reactions were lower in the combined group compared to the conventional group (P <0.05).
Banxia Xiexin Decoction can reduce the levels of tumor factors, promote the improvements of gastrointestinal function, immunity and nutritional status, and play a role in reducing toxicity and increasing efficiency in patients with locally advanced gastric cancer receiving SOX regimen chemotherapy after surgery.